TeaRx LLC

1 clinical trials · Sponsor

Record	Firm	Date
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement (NCT03088358)	TeaRx LLC	2013-08-01

Every clearance here is in the API, with alerts when new ones post.